Sale!

GFRA1 Gene Central Hypoventilation Syndrome Congenital Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The GFRA1 gene test for Congenital Central Hypoventilation Syndrome (CCHS) is a genetic screening designed to detect mutations in the GFRA1 gene, which have been associated with the development of this rare condition. CCHS, also known as Ondine’s curse, is characterized by a failure of the autonomic control of breathing, particularly during sleep, leading to inadequate ventilation and a risk of severe respiratory and neurological complications.

This test, offered at DNA Labs UAE, plays a crucial role in diagnosing the syndrome, enabling early intervention and management strategies to mitigate health risks associated with the condition. The cost of the GFRA1 gene test for CCHS at DNA Labs UAE is 4400 AED. Given the complexity and rarity of the condition, this genetic test is a valuable tool for affected families, providing them with essential information for making informed health and lifestyle decisions.

Description

GFRA1 Gene Central Hypoventilation Syndrome Congenital Genetic Test

At DNA Labs UAE, we offer the GFRA1 Gene Central Hypoventilation Syndrome Congenital Genetic Test for individuals suspected of having Central Hypoventilation Syndrome, Congenital (CHSC). CHSC, also known as Hirschsprung disease type 2, is a rare genetic disorder characterized by abnormal control of breathing, particularly during sleep.

Test Components: The GFRA1 Gene Central Hypoventilation Syndrome Congenital Genetic Test includes the following components:

Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Dysmorphology
Doctor: Pediatrics
Test Department: Genetics

Pre Test Information: Before undergoing the GFRA1 Gene Central Hypoventilation Syndrome Congenital Genetic Test, it is important to provide the clinical history of the patient who is being tested. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by CHSC and to discuss the implications of the test results.

Test Details: The GFRA1 gene is associated with CHSC. NGS genetic testing, which utilizes Next-Generation Sequencing technology, can analyze multiple genes simultaneously. In the case of CHSC, NGS genetic testing can identify mutations or variants in the GFRA1 gene that may be responsible for the condition. This comprehensive analysis provides more detailed information compared to traditional sequencing methods.

NGS genetic testing for CHSC can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It is also valuable for genetic counseling and family planning purposes.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can offer appropriate guidance and support.

Test Name	GFRA1 Gene Central hypoventilation syndrome congenital Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Dysmorphology
Doctor	Pediatrics
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for GFRA1 Gene Central hypoventilation syndrome, congenital NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GFRA1 Gene Central hypoventilation syndrome, congenital NGS Genetic DNA Test gene GFRA1
Test Details	The GFRA1 gene is associated with a condition called Central Hypoventilation Syndrome, Congenital (CHSC), also known as Hirschsprung disease type 2. CHSC is a rare genetic disorder characterized by abnormal control of breathing, particularly during sleep. Individuals with CHSC may have difficulty sensing low oxygen levels and high carbon dioxide levels, leading to inadequate breathing. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of CHSC, NGS genetic testing can be used to identify mutations or variants in the GFRA1 gene that may be responsible for the condition. This type of testing can provide a more comprehensive analysis of genetic changes compared to traditional sequencing methods. NGS genetic testing for CHSC can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It can also be useful for genetic counseling and family planning purposes. It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate guidance and support.